Isolation and characterization of recombinant single chain fragment variable anti-idiotypic antibody specific to Aspergillus fumigatus membrane protein.
暂无分享,去创建一个
[1] Y. Furuichi,et al. Different buffer effects in selecting HM-1 killer toxin single-chain fragment variable anti-idiotypic antibodies. , 2010, Journal of biochemistry.
[2] T. Munro,et al. A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies. , 2010, Journal of immunological methods.
[3] Y. Furuichi,et al. An improved phage-display panning method to produce an HM-1 killer toxin anti-idiotypic antibody , 2009, BMC biotechnology.
[4] Y. Furuichi,et al. Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution. , 2009, Analytical biochemistry.
[5] S. Dübel,et al. Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus , 2009, PloS one.
[6] Y. Iba,et al. Isolation of antigen/antibody complexes through organic solvent (ICOS) method. , 2009, Biochemical and biophysical research communications.
[7] K. Sugimura,et al. Ig L-chain shuffling for affinity maturation of phage library-derived human anti-human MCP-1 antibody blocking its chemotactic activity. , 2008, Journal of biochemistry.
[8] D. Perlin,et al. A Ser678Pro Substitution in Fks1p Confers Resistance to Echinocandin Drugs in Aspergillus fumigatus , 2007, Antimicrobial Agents and Chemotherapy.
[9] A. Brancale,et al. Phage display identification of functional binding peptides against 4-acetamidophenol (Paracetamol): an exemplified approach to target low molecular weight organic molecules. , 2007, Biochemical and biophysical research communications.
[10] Philip Schulz,et al. Single Chain Fv Antibodies against the 25−35 Aβ Fragment Inhibit Aggregation and Toxicity of Aβ42† , 2006 .
[11] Y. Furuichi,et al. Inhibition of Fungal β-1,3-Glucan Synthase and Cell Growth by HM-1 Killer Toxin Single-Chain Anti-Idiotypic Antibodies , 2006, Antimicrobial Agents and Chemotherapy.
[12] S. Wilczynski,et al. Vaccinations with Recombinant Variants of Aspergillus fumigatus Allergen Asp f 3 Protect Mice against Invasive Aspergillosis , 2006, Infection and Immunity.
[13] M. Motyl,et al. Caspofungin Susceptibility in Aspergillus and Non-Aspergillus Molds: Inhibition of Glucan Synthase and Reduction of β-d-1,3 Glucan Levels in Culture , 2006, Antimicrobial Agents and Chemotherapy.
[14] Zhen-ping Zhu,et al. Single Variable Domain-IgG Fusion , 2006, Journal of Biological Chemistry.
[15] A. Vekhoff,et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. , 2006, The Journal of infectious diseases.
[16] U. Reichard,et al. Fungal Antigens Expressed during Invasive Aspergillosis , 2005, Infection and Immunity.
[17] Y. Adachi,et al. Anti-fungal activity of sulfamethoxazole toward Aspergillus species. , 2005, Biological & pharmaceutical bulletin.
[18] Andreas Plückthun,et al. An antibody library for stabilizing and crystallizing membrane proteins – selecting binders to the citrate carrier CitS , 2004, FEBS letters.
[19] D. Perlin,et al. Molecular Evaluation of the Plasma Membrane Proton Pump from Aspergillus fumigatus , 2002, Antimicrobial Agents and Chemotherapy.
[20] D. Denning,et al. In Vitro Activities of Terbinafine againstAspergillus Species in Comparison with Those of Itraconazole and Amphotericin B , 2001, Antimicrobial Agents and Chemotherapy.
[21] B. Kawakami,et al. Characterization of DNA polymerase from Pyrococcus sp. strain KOD1 and its application to PCR , 1997, Applied and environmental microbiology.
[22] J. Nielsen,et al. Isolation of a gene involved in 1,3-beta-glucan synthesis in Aspergillus nidulans and purification of the corresponding protein , 1996, Journal of bacteriology.
[23] J. Bye,et al. Human anti‐self antibodies with high specificity from phage display libraries. , 1993, The EMBO journal.
[24] E. Kabat,et al. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites. , 1991, Journal of immunology.
[25] T. Yamamoto,et al. Application of monoclonal antibodies to the isolation and characterization of a killer toxin secreted by Hansenula mrakii , 1986, FEBS letters.